home.social

#pharma — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #pharma, aggregated by home.social.

  1. Helus Pharma corrects TARA Mind partnership announcement for HLP003 Phase 3 recruitment in major depressive disorder. FDA Breakthrough Therapy Designation underscores clinical potential. #MentalHealth #Pharma

  2. Tonix Pharmaceuticals secures major GPO agreement covering 35M commercial lives for TONMYA fibromyalgia treatment, expanding patient access alongside existing Medicaid coverage in 38 states. #Pharma #Healthcare

  3. Tonix Pharmaceuticals secures major GPO agreement covering 35M commercial lives for TONMYA fibromyalgia treatment, expanding patient access alongside existing Medicaid coverage in 38 states. #Pharma #Healthcare

  4. Tonix Pharmaceuticals secures major GPO agreement covering 35M commercial lives for TONMYA fibromyalgia treatment, expanding patient access alongside existing Medicaid coverage in 38 states. #Pharma #Healthcare

  5. Tonix Pharmaceuticals secures major GPO agreement covering 35M commercial lives for TONMYA fibromyalgia treatment, expanding patient access alongside existing Medicaid coverage in 38 states. #Pharma #Healthcare

  6. Tonix Pharmaceuticals reports strong Q1 2026 results with TONMYA fibromyalgia treatment showing growth in prescriptions and patient access. New managed care agreement covers 35M lives. #Biotech #Pharma

  7. Tonix Pharmaceuticals reports strong Q1 2026 results with TONMYA fibromyalgia treatment showing growth in prescriptions and patient access. New managed care agreement covers 35M lives. #Biotech #Pharma

  8. Tonix Pharmaceuticals reports strong Q1 2026 results with TONMYA fibromyalgia treatment showing growth in prescriptions and patient access. New managed care agreement covers 35M lives. #Biotech #Pharma

  9. Tonix Pharmaceuticals reports strong Q1 2026 results with TONMYA fibromyalgia treatment showing growth in prescriptions and patient access. New managed care agreement covers 35M lives. #Biotech #Pharma

  10. Tonix Pharmaceuticals reports strong Q1 2026 results with TONMYA fibromyalgia treatment showing growth in prescriptions and patient access. New managed care agreement covers 35M lives. #Biotech #Pharma

  11. [#TRADESHOW] #CPHI & #PMEC #China 2026 from June 16 to 18, 2026, at the #Shanghai New #International #Expo #Center (#SNIEC). As #Asia’s leading #pharmaceutical #sourcing and #networking #platform, the #exhibition #event has more than 20 years of experience connecting #Chinese and international #pharma professionals. It serves as a key #meeting point for #innovation, #SupplyChain #collaboration, and #market expansion within the #global pharmaceutical #ecosystem. cnbusinessforum.com/event/cphi

  12. [#TRADESHOW] #CPHI & #PMEC #China 2026 from June 16 to 18, 2026, at the #Shanghai New #International #Expo #Center (#SNIEC). As #Asia’s leading #pharmaceutical #sourcing and #networking #platform, the #exhibition #event has more than 20 years of experience connecting #Chinese and international #pharma professionals. It serves as a key #meeting point for #innovation, #SupplyChain #collaboration, and #market expansion within the #global pharmaceutical #ecosystem. cnbusinessforum.com/event/cphi

  13. [#TRADESHOW] #CPHI & #PMEC #China 2026 from June 16 to 18, 2026, at the #Shanghai New #International #Expo #Center (#SNIEC). As #Asia’s leading #pharmaceutical #sourcing and #networking #platform, the #exhibition #event has more than 20 years of experience connecting #Chinese and international #pharma professionals. It serves as a key #meeting point for #innovation, #SupplyChain #collaboration, and #market expansion within the #global pharmaceutical #ecosystem. cnbusinessforum.com/event/cphi

  14. The GLP-1 supply chain as Law I migration: as demand for peptides explodes, the bottleneck shifts from drug discovery to manufacturing capacity. Same pattern as AI infra — the physical constraint determines the ceiling.

  15. The GLP-1 supply chain as Law I migration: as demand for peptides explodes, the bottleneck shifts from drug discovery to manufacturing capacity. Same pattern as AI infra — the physical constraint determines the ceiling.

    #GLP1 #Pharma #Bottleneck

  16. europesays.com/ch/65327/ Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer in India #immunotherapy #launch #LungCancer #Pharma #Roche

  17. The R Consortium R Submissions Working Group continues to help move regulatory submissions with R from concept to practical implementation.

    In Pilot 4, the group explored WebAssembly and Docker containers for packaging and running an R Shiny app for regulatory review.

    FDA feedback showed both approaches are technically feasible, highlighting practical needs around reproducibility, security, reviewer usability, and operational readiness.

    Read more: r-consortium.org/posts/beyond-

  18. The R Consortium R Submissions Working Group continues to help move regulatory submissions with R from concept to practical implementation.

    In Pilot 4, the group explored WebAssembly and Docker containers for packaging and running an R Shiny app for regulatory review.

    FDA feedback showed both approaches are technically feasible, highlighting practical needs around reproducibility, security, reviewer usability, and operational readiness.

    Read more: r-consortium.org/posts/beyond-

    #rstats #pharma

  19. The R Consortium R Submissions Working Group continues to help move regulatory submissions with R from concept to practical implementation.

    In Pilot 4, the group explored WebAssembly and Docker containers for packaging and running an R Shiny app for regulatory review.

    FDA feedback showed both approaches are technically feasible, highlighting practical needs around reproducibility, security, reviewer usability, and operational readiness.

    Read more: r-consortium.org/posts/beyond-

    #rstats #pharma

  20. The R Consortium R Submissions Working Group continues to help move regulatory submissions with R from concept to practical implementation.

    In Pilot 4, the group explored WebAssembly and Docker containers for packaging and running an R Shiny app for regulatory review.

    FDA feedback showed both approaches are technically feasible, highlighting practical needs around reproducibility, security, reviewer usability, and operational readiness.

    Read more: r-consortium.org/posts/beyond-

    #rstats #pharma

  21. The R Consortium R Submissions Working Group continues to help move regulatory submissions with R from concept to practical implementation.

    In Pilot 4, the group explored WebAssembly and Docker containers for packaging and running an R Shiny app for regulatory review.

    FDA feedback showed both approaches are technically feasible, highlighting practical needs around reproducibility, security, reviewer usability, and operational readiness.

    Read more: r-consortium.org/posts/beyond-

    #rstats #pharma

  22. 🔐 West Pharmaceutical sotto attacco: sistemi cifrati e operatività a rischio. La resilienza cyber è ormai cruciale per la sanità. #Cybersecurity #Pharma

    🔗 tomshw.it/hardware/west-pharma

  23. 🔐 West Pharmaceutical sotto attacco: sistemi cifrati e operatività a rischio. La resilienza cyber è ormai cruciale per la sanità. #Cybersecurity #Pharma

    🔗 tomshw.it/hardware/west-pharma

  24. 🔐 West Pharmaceutical sotto attacco: sistemi cifrati e operatività a rischio. La resilienza cyber è ormai cruciale per la sanità. #Cybersecurity #Pharma

    🔗 tomshw.it/hardware/west-pharma

  25. R Consortium working groups are a practical on-ramp into the R community: open collaboration, technical contribution, and domain-specific work - often without needing to be from an R Consortium member company.

    The nlmixr2 working group has a new post on an invited seminar with FDA quantitative clinical pharmacology reviewers, covering open source tools, regulatory review, reproducibility, model interchange, and reviewer-friendly workflows.

    Read it:
    blog.nlmixr2.org/blog/2026-04-

    #RStats #Pharma

  26. R Consortium working groups are a practical on-ramp into the R community: open collaboration, technical contribution, and domain-specific work - often without needing to be from an R Consortium member company.

    The nlmixr2 working group has a new post on an invited seminar with FDA quantitative clinical pharmacology reviewers, covering open source tools, regulatory review, reproducibility, model interchange, and reviewer-friendly workflows.

    Read it:
    blog.nlmixr2.org/blog/2026-04-

  27. R Consortium working groups are a practical on-ramp into the R community: open collaboration, technical contribution, and domain-specific work - often without needing to be from an R Consortium member company.

    The nlmixr2 working group has a new post on an invited seminar with FDA quantitative clinical pharmacology reviewers, covering open source tools, regulatory review, reproducibility, model interchange, and reviewer-friendly workflows.

    Read it:
    blog.nlmixr2.org/blog/2026-04-

    #RStats #Pharma

  28. R Consortium working groups are a practical on-ramp into the R community: open collaboration, technical contribution, and domain-specific work - often without needing to be from an R Consortium member company.

    The nlmixr2 working group has a new post on an invited seminar with FDA quantitative clinical pharmacology reviewers, covering open source tools, regulatory review, reproducibility, model interchange, and reviewer-friendly workflows.

    Read it:
    blog.nlmixr2.org/blog/2026-04-

    #RStats #Pharma

  29. R Consortium working groups are a practical on-ramp into the R community: open collaboration, technical contribution, and domain-specific work - often without needing to be from an R Consortium member company.

    The nlmixr2 working group has a new post on an invited seminar with FDA quantitative clinical pharmacology reviewers, covering open source tools, regulatory review, reproducibility, model interchange, and reviewer-friendly workflows.

    Read it:
    blog.nlmixr2.org/blog/2026-04-

    #RStats #Pharma

  30. Voyageur Pharmaceuticals acquires groundbreaking iodine extraction technology, appoints Dr. Brian Mueller as Chemistry Director. Aims to revolutionize contrast media production with 90% yield, environmentally friendly process. Potential game-changer in pharmaceutical manufacturing. #Pharma #Innovation

  31. Voyageur Pharmaceuticals acquires groundbreaking iodine extraction technology, appoints Dr. Brian Mueller as Chemistry Director. Aims to revolutionize contrast media production with 90% yield, environmentally friendly process. Potential game-changer in pharmaceutical manufacturing. #Pharma #Innovation

  32. Voyageur Pharmaceuticals acquires groundbreaking iodine extraction technology, appoints Dr. Brian Mueller as Chemistry Director. Aims to revolutionize contrast media production with 90% yield, environmentally friendly process. Potential game-changer in pharmaceutical manufacturing. #Pharma #Innovation

  33. Nutriband Inc. achieves significant milestones in 2025, strengthens abuse-deterrent pharmaceutical technology with strategic advances and FDA engagement. Focused on AVERSA(TM) Fentanyl development and shareholder value. #Pharma #Innovation

  34. Nutriband Inc. achieves significant milestones in 2025, strengthens abuse-deterrent pharmaceutical technology with strategic advances and FDA engagement. Focused on AVERSA(TM) Fentanyl development and shareholder value. #Pharma #Innovation

  35. Nutriband Inc. achieves significant milestones in 2025, strengthens abuse-deterrent pharmaceutical technology with strategic advances and FDA engagement. Focused on AVERSA(TM) Fentanyl development and shareholder value. #Pharma #Innovation